A detailed history of Clearstead Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Clearstead Advisors, LLC holds 296 shares of TAK stock, worth $3,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
296
Previous 586 49.49%
Holding current value
$3,898
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$13.0 - $15.08 $3,770 - $4,373
-290 Reduced 49.49%
296 $4,000
Q1 2024

May 14, 2024

BUY
$13.89 - $15.04 $7,792 - $8,437
561 Added 2244.0%
586 $8,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $263 - $328
-20 Reduced 44.44%
25 $0
Q4 2020

Feb 11, 2021

BUY
$15.39 - $18.97 $692 - $853
45 New
45 $1,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.